Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.05
-0.16 (-0.75%)
Nov 21, 2024, 1:38 PM EST - Market open
KNSA Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,520 | 1,234 | 1,042 | 811 | 1,203 | 607 | |
Market Cap Growth | 46.08% | 18.45% | 28.46% | -32.59% | 98.17% | -56.32% | |
Enterprise Value | 1,318 | 1,046 | 848 | 617 | 840 | 351 | |
Last Close Price | 21.21 | 17.54 | 14.98 | 11.77 | 17.67 | 11.06 | |
PE Ratio | - | 87.60 | 5.68 | - | - | - | |
PS Ratio | 3.92 | 4.57 | 4.73 | 21.04 | - | - | |
PB Ratio | 3.50 | 2.81 | 2.63 | 4.38 | 3.86 | 2.69 | |
P/TBV Ratio | 4.23 | 2.93 | 2.76 | 4.89 | 3.86 | 2.69 | |
P/FCF Ratio | 137.20 | 93.67 | 182.67 | - | - | - | |
P/OCF Ratio | 135.49 | 92.76 | 179.37 | - | - | - | |
EV/Sales Ratio | 3.43 | 3.87 | 3.85 | 16.02 | - | - | |
EV/EBITDA Ratio | - | - | 69.62 | - | - | - | |
EV/EBIT Ratio | - | - | 86.73 | - | - | - | |
EV/FCF Ratio | 118.71 | 79.39 | 148.64 | - | - | - | |
Debt / Equity Ratio | 0.02 | 0.03 | 0.01 | 0.03 | 0.02 | 0.01 | |
Debt / EBITDA Ratio | - | - | 0.38 | - | - | - | |
Debt / FCF Ratio | 0.95 | 0.93 | 1.04 | - | - | - | |
Asset Turnover | 0.74 | 0.55 | 0.64 | 0.13 | - | - | |
Inventory Turnover | 5.52 | 3.41 | 3.72 | - | - | - | |
Quick Ratio | 2.59 | 3.58 | 4.48 | 4.15 | 10.16 | 8.39 | |
Current Ratio | 3.24 | 4.34 | 5.16 | 4.38 | 10.46 | 8.68 | |
Return on Equity (ROE) | -2.15% | 3.37% | 63.10% | -63.55% | -60.06% | -64.15% | |
Return on Assets (ROA) | -3.16% | -3.19% | 1.76% | -33.63% | -32.57% | -36.85% | |
Return on Capital (ROIC) | -3.79% | -3.69% | 2.06% | -38.39% | -35.96% | -41.88% | |
Earnings Yield | -0.60% | 1.14% | 17.60% | -19.48% | -13.42% | -26.67% | |
FCF Yield | 0.73% | 1.07% | 0.55% | -15.63% | -11.37% | -26.62% | |
Buyback Yield / Dilution | -1.53% | -2.13% | -2.69% | -10.89% | -14.42% | -82.92% | |
Total Shareholder Return | -1.53% | -2.13% | -2.69% | -10.89% | -14.42% | -82.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.